Observational Study of Wearable Health Monitoring Device
NCT ID: NCT05368389
Last Updated: 2024-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
33 participants
OBSERVATIONAL
2022-11-03
2023-06-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
NCT01808053
Surgical Ward Innovation: Telemonitoring Controlled by Healthdot
NCT05956210
Evaluating the Accuracy of an Integrated Vital Sign Measurement Platform
NCT03589716
Performance Assessment of a Remote Patient Monitoring Device
NCT02570906
Evaluation of Performance, Usability, and Reliability of a Novel Device for Continuous Collection of Physiological Data
NCT03257189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthdot Patients
This group represents the patient who have undergone a bariatric procedure and had the Healthdot device attached and had data collected from the device for 10 days.
Healthdot attachment
The wearable health monitoring device "Healthdot 5" will be attached to the patient's skin at left lower rib and data like heart rate, respiratory rate, posture and activity will be collected for 10 days.
A questionnaire will be sent to patients to fill out at the 10th day after the device attachment.
Healthdot providers
This group represents the providers or study/hospital staff who were involved in the attachment, recruitment, and enrollment of the Healthdot patients.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Healthdot attachment
The wearable health monitoring device "Healthdot 5" will be attached to the patient's skin at left lower rib and data like heart rate, respiratory rate, posture and activity will be collected for 10 days.
A questionnaire will be sent to patients to fill out at the 10th day after the device attachment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Commitment to wear device without removing for entire study period.
* Located within a driving distance from Mayo Clinic in Rochester, Minnesota during study duration.
* Reside in an area with 4G or 5G connectivity based on cellphone provider maps for T-Mobile or AT\&T.
* Subject clear of any dermatologic health diagnosis that may impede the ability of the device to adhere properly.
Exclusion Criteria
* Unwillingness to utilize email address for device instructions, surveys, and reminders.
* Lifestyle that would have the device exposed to excessive elements for a prolonged period of time outside the parameters of normal operation of the device.
* Patient is expected/anticipated to fly (use an airplane) before study completion (before Day 10).
* Subjects with a pacemaker or an implanted electronic device.
* Subjects scheduled or likely to conduct MRI within the study period.
* Left lower rib (place where Healthdot will be applied) is involved in the area of surgery, area of disinfection or area where bandages are needed.
* Patients with severe systemic diseases.
22 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philips Healthcare
INDUSTRY
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric J. Vargas Valls
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric K Vargas Valls, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karl Akiki
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-007489
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.